Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00492778
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:15.107639+00:00
Published At
2023-03-29T00:00:00+00:00
Record Updated At
2023-03-29
Results Posted At
2023-03-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation", "Endometrial Mucinous Adenocarcinoma", "Endometrial Squamous Cell Carcinoma", "Recurrent Endometrial Clear Cell Adenocarcinoma", "Recurrent Endometrial Endometrioid Adenocarcinoma", "Recurrent Endometrial Serous Adenocarcinoma", "Recurrent Endometrial Undifferentiated Carcinoma", "Recurrent Uterine Corpus Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-29"
protocolSection.identificationModule.nctId
"NCT00492778"
protocolSection.identificationModule.officialTitle
"A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-03-29"

Study condition terms

  • Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation (protocolSection.conditionsModule.conditions)
  • Endometrial Mucinous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Clear Cell Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Undifferentiated Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.